Advertisement

Pathology of Ovary: Epithelial Tumours

  • Pranab Dey
Chapter

Abstract

This chapter describes the histological features of different epithelial neoplasms of ovary. The epithelial ovarian tumours are mainly serous, mucinous, endometrioid, clear cell and Brenner’s tumour. Each of these group is classified as benign, borderline and malignant. The gross and histopathology of the tumours along with cytology and immunohistochemistry of these lesions have been highlighted in details.

Keywords

Serous cystadenoma Serous borderline tumour serous carcinoma Low grade serous carcinoma High grade serous carcinoma Peritoneal implant Chemotherapy response score Mucinous cystadenoma Borderline mucinous tumour Mucinous carcinoma Pseudomyxoma Endometrioid carcinoma Clear cell carcinoma Brenner tumour Borderline brenner tumour Malignant Brenner tumour Undifferentiated carcinoma Carcinosarcoma Adenosarcoma Endometrial stromal sarcoma Large cell neuroendocrine tumour Small cell carcinoma Seromucinous carcinoma 

Reference

  1. 1.
    Kurman RJ, Carcangiu ML, Herrington S, Young RH. WHO classification of tumours of female genital reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014.Google Scholar

Selected References

  1. Acs G. Serous and mucinous borderline (low malignant potential) tumours of the ovary. Am J Clin Pathol. 2005;123(Suppl):S13–57.PubMedGoogle Scholar
  2. Arnogiannaki N, Grigoriadis C, Zygouris D, Terzakis E, Sebastiadou M, Tserkezoglou A. Proliferative Brenner tumour of the ovary. Clinicopathological study of two cases and review of the literature. Eur J Gynaecol Oncol. 2011;32(5):576–8.PubMedGoogle Scholar
  3. Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B. Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol. 2014;134(2):410–8.CrossRefGoogle Scholar
  4. Brown J, Frumovitz M. Mucinous tumours of the ovary: current thoughts on diagnosis and management. Curr Oncol Rep. 2014;16(6):389.CrossRefGoogle Scholar
  5. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumours. Am J Surg Pathol. 1996;20(11):1319–30.CrossRefGoogle Scholar
  6. Cantrell LA, Van Le L. Carcinosarcoma of the ovary a review. Obstet Gynecol Surv. 2009;64(10):673–80.CrossRefGoogle Scholar
  7. Czernobilsky B, Silverman BB, Mikuta JJ. Endometrioid carcinoma of the ovary. A clinicopathologic study of 75 cases. Cancer. 1970;26(5):1141–52.CrossRefGoogle Scholar
  8. De Cecio R, Cantile M, Collina F, Marra L, Santonastaso C, Scaffa C, Botti G, Losito NS. Borderline Brenner tumour of the ovary: a case report with immunohistochemical and molecular study. J Ovarian Res. 2014;7:101.CrossRefGoogle Scholar
  9. del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of the ovary: a review of the literature. Gynecol Oncol. 2012;125(1):271–7.CrossRefGoogle Scholar
  10. DePriest PD, Banks ER, Powell DE, van Nagell JR Jr, Gallion HH, Puls LE, Hunter JE, Kryscio RJ, Royalty MB. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol. 1992;47(1):71–5.CrossRefGoogle Scholar
  11. Diaz-Padilla I, Malpica AL, Minig L, Chiva LM, Gershenson DM, Gonzalez-Martin A. Ovarian low-grade serous carcinoma: a comprehensive update. Gynecol Oncol. 2012;126(2):279–85.CrossRefGoogle Scholar
  12. Dietel M, Hauptmann S. Serous tumours of low malignant potential of the ovary. Diagnostic pathology. Virchows Arch. 2000;436(5):403–12.CrossRefGoogle Scholar
  13. Fischerova D, Zikan M, Dundr P, Cibula D. Diagnosis, treatment, and follow-up of borderline ovarian tumours. Oncologist. 2012;17(12):1515–33.CrossRefGoogle Scholar
  14. Fujiwara K, Shintani D, Nishikawa T. Clear-cell carcinoma of the ovary. Ann Oncol. 2016;27(Suppl 1):i50–2.CrossRefGoogle Scholar
  15. Gezginç K, Karatayli R, Yazici F, Acar A, Çelik Ç, Çapar M, Tavli L. Malignant Brenner tumour of the ovary: analysis of 13 cases. Int J Clin Oncol. 2012;17(4):324–9.CrossRefGoogle Scholar
  16. Glasspool RM, McNeish IA. Clear cell carcinoma of ovary and uterus. Curr Oncol Rep. 2013;15(6):566–72.CrossRefGoogle Scholar
  17. Hart WR. Borderline epithelial tumours of the ovary. Mod Pathol. 2005a;18(Suppl 2):S33–50.CrossRefGoogle Scholar
  18. Hart WR. Mucinous tumours of the ovary: a review. Int J Gynecol Pathol. 2005b;24(1):4–25.PubMedGoogle Scholar
  19. Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA. Low-grade serous ovarian cancer: a review. Gynecol Oncol. 2016;143(2):433–8.CrossRefGoogle Scholar
  20. Khunamornpong S, Settakorn J, Sukpan K, et al. Mucinous tumour of low malignant potential (“borderline” or “atypical proliferative” tumour) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol. 2011;30:18–230.Google Scholar
  21. Kondi-Pafiti A, Kairi-Vassilatou E, Iavazzo C, Vouza E, Mavrigiannaki P, Kleanthis C, Vlahodimitropoulos D, Liapis A. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumours. Arch Gynecol Obstet. 2012;285(6):1699–702.CrossRefGoogle Scholar
  22. Lee KR, Scully RE. Mucinous tumours of the ovary: a clinicopathologic study of 196 borderline tumours (of intestinal type) and carcinomas,including an evaluation of 11 cases with pseudomyxoma peritonei. Am J Surg Pathol. 2000;24:1447–64.CrossRefGoogle Scholar
  23. McKenney JK, Balzer BL, Longacre TA. Patterns of stromal invasion in ovarian serous tumours of low malignant potential (borderline tumours): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol. 2006a;30:1209–21.CrossRefGoogle Scholar
  24. McKenney JK, Balzer BL, Longacre TA. Lymph node involvement in ovarian serous tumours of low malignant potential (borderline tumours): pathology, prognosis, and proposed classification. Am J Surg Pathol. 2006b;30:614–24.CrossRefGoogle Scholar
  25. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumours of low malignant potential. Cancer. 1986;57(6):1240–7.CrossRefGoogle Scholar
  26. Naik JD, Seligmann J, Perren TJ. Mucinous tumours of the ovary. J Clin Pathol. 2012;65(7):580.CrossRefGoogle Scholar
  27. Oliva E, Egger JF, Young RH. Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade. Am J Surg Pathol. 2014;38(3):305–15.CrossRefGoogle Scholar
  28. Perren TJ. Mucinous epithelial ovarian carcinoma. Ann Oncol. 2016;27(Suppl 1):i53–7.CrossRefGoogle Scholar
  29. Prat J. Ovarian tumours of borderline malignancy (tumours of low malignant potential): a critical appraisal. Adv Anat Pathol. 1999;6(5):247–74.CrossRefGoogle Scholar
  30. Ramalingam P. Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer. Oncology. 2016;30(2):166–76.PubMedGoogle Scholar
  31. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92:85–91.CrossRefGoogle Scholar
  32. Scully RE. Small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol. 1993;12(2):148–52.CrossRefGoogle Scholar
  33. Shakuntala PN, Uma Devi K, Shobha K, Bafna UD, Geetashree M. Pure large cell neuroendocrine carcinoma of ovary: a rare clinical entity and review of literature. Case Rep Oncol Med. 2012;2012:120727.PubMedPubMedCentralGoogle Scholar
  34. Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumours: atypical proliferative (borderline) tumours, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol. 2002;26(12):1529–41.CrossRefGoogle Scholar
  35. Sinha R, Sundaram M. Endometrial stromal sarcoma from endometriosis. J Minim Invasive Gynecol. 2010;17(5):541–2.CrossRefGoogle Scholar
  36. Smith Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am J Surg Pathol. 2003;27(6):725–36.CrossRefGoogle Scholar
  37. Vang R, Shih IM, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009;16(5):267–82.CrossRefGoogle Scholar
  38. Voutsadakis IA. Large cell neuroendocrine carcinoma of the ovary: a pathologic entity in search of clinical identity. World J Clin Oncol. 2014;5(2):36–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Pranab Dey
    • 1
  1. 1.Post Graduate Institute of Medical Education and Research (PGIMER)ChandigarhIndia

Personalised recommendations